How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA? (Q53410422)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2009

edit

Language	Label	Description	Also known as
English	How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA?	scientific article published in March 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

title

How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

author name string

Peter C Taylor

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

publication date

1 March 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

published in

Nature Clinical Practice Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

page(s)

126-127

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

cites work

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNCPRHEUM1022

retrieved

21 January 2018

Double-blinded infliximab dose escalation in patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19252515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19252515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19252515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19252515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19252515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19252515

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NCPRHEUM1022

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

Fatcat ID

release_h3httsivqrfc7pwydshzcfzale

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/h3httsivqrfc7pwydshzcfzale

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

19252515

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19252515

retrieved

14 May 2018

reference URL

http://europepmc.org/abstract/MED/19252515

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53410422&oldid=1844462066"